Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
48,932,355
-
Total 13F shares
-
25,705,114
-
Share change
-
+4,276,634
-
Total reported value
-
$1,146,849,855
-
Put/Call ratio
-
148%
-
Price per share
-
$44.62
-
Number of holders
-
180
-
Value change
-
+$196,048,585
-
Number of buys
-
104
-
Number of sells
-
70
Institutional Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q3 2022
As of 30 Sep 2022,
Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) was held by
180 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,705,114 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., Fairmount Funds Management LLC, RTW INVESTMENTS, LP, PFM Health Sciences, LP, Avidity Partners Management LP, ALETHEA CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Nuveen Asset Management, LLC, and Point72 Asset Management, L.P..
This page lists
180
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.